Cidara Therapeutics Inc (CDTX) support and resistance · rev $1.3M
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
This page maps Cidara Therapeutics Inc (CDTX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
CDTX currently screens at market cap $6.96B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CDTX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CDTX quote page for the session range and the stock page for the full model.
Not investment advice.